0.3379
price up icon5.59%   0.0179
after-market Handel nachbörslich: .35 0.0121 +3.58%
loading
Schlusskurs vom Vortag:
$0.32
Offen:
$0.32
24-Stunden-Volumen:
694.91K
Relative Volume:
1.40
Marktkapitalisierung:
$28.50M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-126.61M
KGV:
-0.1724
EPS:
-1.96
Netto-Cashflow:
$-60.14M
1W Leistung:
-7.35%
1M Leistung:
-12.12%
6M Leistung:
-69.56%
1J Leistung:
-85.56%
1-Tages-Spanne:
Value
$0.32
$0.3521
1-Wochen-Bereich:
Value
$0.3004
$0.37
52-Wochen-Spanne:
Value
$0.3004
$3.65

Generation Bio Co Stock (GBIO) Company Profile

Name
Firmenname
Generation Bio Co
Name
Telefon
857-529-5908
Name
Adresse
301 BINNEY STREET, CAMBRIDGE
Name
Mitarbeiter
115
Name
Twitter
@generationbio
Name
Nächster Verdiensttermin
2025-03-12
Name
Neueste SEC-Einreichungen
Name
GBIO's Discussions on Twitter

Vergleichen Sie GBIO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
GBIO
Generation Bio Co
0.3379 28.50M 0 -126.61M -60.14M -1.96
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Generation Bio Co Stock (GBIO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-10-19 Herabstufung TD Cowen Outperform → Market Perform
2022-11-08 Eingeleitet Canaccord Genuity Buy
2021-12-14 Herabstufung William Blair Outperform → Mkt Perform
2021-06-08 Eingeleitet JMP Securities Mkt Outperform
2021-02-24 Eingeleitet William Blair Outperform
2021-02-18 Eingeleitet Needham Buy
2020-07-07 Eingeleitet Cowen Outperform
2020-07-07 Eingeleitet JP Morgan Overweight
2020-07-07 Eingeleitet Jefferies Buy
2020-07-07 Eingeleitet Wedbush Outperform
Alle ansehen

Generation Bio Co Aktie (GBIO) Neueste Nachrichten

pulisher
Jun 17, 2025

Post Bio announced on the 17th that it held a kick-off event for the open innovation project and sig.. - 매일경제

Jun 17, 2025
pulisher
Jun 16, 2025

64x Bio Launches AAV Apex Suite to Power the Next Generation of Gene Therapy Manufacturing - Business Wire

Jun 16, 2025
pulisher
Jun 14, 2025

Millennium Management LLC Makes New $97,000 Investment in Generation Bio Co. (NASDAQ:GBIO) - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

Two Sigma Investments LP Sells 29,496 Shares of Generation Bio Co. (NASDAQ:GBIO) - Defense World

Jun 13, 2025
pulisher
Jun 11, 2025

Squarepoint Ops LLC Takes Position in Generation Bio Co. (NASDAQ:GBIO) - Defense World

Jun 11, 2025
pulisher
Jun 09, 2025

What Did We Note About Insider Trading At Generation Bio Co (NASDAQ: GBIO)? - Stocksregister

Jun 09, 2025
pulisher
Jun 05, 2025

Generation Bio Elects Directors and Approves Key Proposals - TipRanks

Jun 05, 2025
pulisher
Jun 03, 2025

Deutsche Bank AG Buys 160,822 Shares of Generation Bio Co. (NASDAQ:GBIO) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Layoff Tracker: Keros Cuts 45% of Workforce Along With Pulmonary Hypertension Drug - BioSpace

Jun 02, 2025
pulisher
May 28, 2025

Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference | GBIO Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference - The Manila Times

May 28, 2025
pulisher
May 28, 2025

Generation Bio Reveals Latest T Cell Therapy Progress: CEO Set for Major Jefferies Healthcare Conference Spotlight - Stock Titan

May 28, 2025
pulisher
May 27, 2025

Generation Bio’s SWOT analysis: t-cell targeting tech reshapes stock outlook By Investing.com - Investing.com South Africa

May 27, 2025
pulisher
May 27, 2025

D. E. Shaw & Co. Inc. Has $366,000 Position in Generation Bio Co. (NASDAQ:GBIO) - Defense World

May 27, 2025
pulisher
May 27, 2025

Generation Bio’s SWOT analysis: t-cell targeting tech reshapes stock outlook - Investing.com Nigeria

May 27, 2025
pulisher
May 19, 2025

Pharma giant Eli Lilly eyes Houston for $5.9B biomanufacturing plant that could bring over 2,000 jobs - Houston Chronicle

May 19, 2025
pulisher
May 17, 2025

Dimensional Fund Advisors LP Has $420,000 Stock Holdings in Generation Bio Co. (NASDAQ:GBIO) - Defense World

May 17, 2025
pulisher
May 12, 2025

Wedbush Issues Negative Forecast for Generation Bio Earnings - Defense World

May 12, 2025
pulisher
May 10, 2025

Needham & Company LLC Reaffirms “Buy” Rating for Generation Bio (NASDAQ:GBIO) - Defense World

May 10, 2025
pulisher
May 09, 2025

Generation Bio Co (GBIO)’s Market Momentum: Closing Strong at 0.48, Down -6.25 - DWinneX

May 09, 2025
pulisher
May 09, 2025

Generation Bio Co. Reports Reduced Losses and Increased Revenue - TipRanks

May 09, 2025
pulisher
May 08, 2025

Where Generation Bio Stands With Analysts - Benzinga

May 08, 2025
pulisher
May 08, 2025

Needham Reiterates Buy Rating for Generation Bio (GBIO) | GBIO Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results - The Manila Times

May 08, 2025
pulisher
May 07, 2025

Generation Bio earnings beat by $0.08, revenue topped estimates - Investing.com

May 07, 2025
pulisher
May 07, 2025

Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

Metric Deep Dive: Understanding Generation Bio Co (GBIO) Through its Ratios - DWinneX

May 07, 2025
pulisher
May 05, 2025

Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results - ADVFN

May 05, 2025
pulisher
May 02, 2025

Stately Bio Raises $12M Seed to Develop Next Generation Regenerative Medicines with ML-Powered Cellular Imaging Platform - WebWire

May 02, 2025
pulisher
May 01, 2025

Renaissance Technologies LLC Has $1.02 Million Stock Position in Generation Bio Co. (NASDAQ:GBIO) - Defense World

May 01, 2025
pulisher
Apr 29, 2025

Revolutionary Green Innovation: Braskem's Bio-Based Polyethylene Transforms Nonwovens Industry - Stock Titan

Apr 29, 2025
pulisher
Apr 24, 2025

Generation Bio Co [GBIO] stock for 120,759 USD was acquired by Quinn Anthony G. - knoxdaily.com

Apr 24, 2025
pulisher
Apr 24, 2025

GBIO’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com

Apr 24, 2025
pulisher
Apr 24, 2025

Generation Bio Co (GBIO) presents a great opportunity, but the stock is slightly overvalued - uspostnews.com

Apr 24, 2025
pulisher
Apr 22, 2025

Generation Bio Insiders Recover Some Losses, Which Stand At US$115k - simplywall.st

Apr 22, 2025
pulisher
Apr 19, 2025

Generation Bio Co (NASDAQ: GBIO) Stock Is A Good Option To Consider - Stocksregister

Apr 19, 2025
pulisher
Apr 17, 2025

Next-Generation Biomanufacturing Market Current Scenario with Future Trends Analysis to 2031 - openPR.com

Apr 17, 2025
pulisher
Apr 12, 2025

Needham & Company LLC Reaffirms Buy Rating for Generation Bio (NASDAQ:GBIO) - Defense World

Apr 12, 2025
pulisher
Apr 08, 2025

GBIO stock plunges to 52-week low of $0.34 amid market challenges - Investing.com Australia

Apr 08, 2025
pulisher
Apr 08, 2025

GBIO stock plunges to 52-week low of $0.34 amid market challenges By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 04, 2025

LG Innotek, KAIST collaborate for next gen technology - 매일경제

Apr 04, 2025
pulisher
Apr 03, 2025

Baker Hughes Co [BKR] Shares Rise 0.27 % on Wednesday - knoxdaily.com

Apr 03, 2025
pulisher
Apr 02, 2025

Generation Bio stock hits 52-week low at $0.4 amid steep decline - Investing.com Australia

Apr 02, 2025
pulisher
Apr 02, 2025

Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference - The Manila Times

Apr 02, 2025

Finanzdaten der Generation Bio Co-Aktie (GBIO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Generation Bio Co-Aktie (GBIO) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Quinn Anthony G.
Director
Jan 13 '25
Buy
0.97
85,000
82,450
299,286
Howze Yalonda
CHIEF LEGAL OFFICER
Oct 15 '24
Option Exercise
2.42
3,347
8,100
15,169
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):